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1. Introduction 
ATP:protein phosphotransferases (EC 2.7.1.37) 
(protein kinases, PK) have emerged as important 
regulatory factors of many cellular processes [ 11. In 
addition to CAMP- and CGMP-dependent enzymes, 
cyclic nucleotideindependent PK have been 
characterized in several mammalian tissues [I] and 
it has been suggested that they may play important 
roles in glycogen [2] and protein [3] metabolism. 
As suggested [4], in vivo modulation of PK activities 
may involve endogenous protein factors, acting either 
as inhibitor or activator of specific PK activities. Two 
types of small molecular weight inhibitors have been 
characterized in mammalian tissues: the heat stable 
inhibitory protein (HSIP) [5] which selectively 
inhibits the catalytic subunit of CAMP-dependent PK; 
and a type II heat-stable factor active on both 
CAMP-dependent and -independent PK [6]. 
This paper reports the isolation and characterization 
from bovine adrenal cortex cytosol of yet another 
heat-stable macromolecular PK inhibitor. However, in 
contrast to the factors mentioned, it was found to 
specifically inhibit a particular type of cyclic 
nucleotide-independent PK activity (PK G, which 
uses GTP as well as ATP as phosphoryl donor) 
isolated from the same tissue. After purification to 
homogeneity, the PK G inhibitor (PK G I) was 
obtained as a polydisperse aggregate which dissociated 
into a 16 500 Mr moiety upon sodium dodecyl 
sulfate (SDS)-polyacrylamide gel electrophoresis. 
In addition to its interest as a tool for the 
biochemical study of protein kinases, this specific 
endogenous factor may be of great biological 
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significance for the modulation of CAMP-independent 
PK G activity and hence for the regulation of intra- 
cellular phosphorylation-dephosphorylation 
processes. 
2. Materials and methods 
[Y-~~P]ATP (20 Ci/mmol) and [T-“P]GTP 
(25 Ci/mmol) were purchased from the Radio- 
Chemical Center (Amersham) and Na “‘1 from the CEA 
(Saclay). Phosphocellulose (P-l 1) and DEAE cellulose 
(DE-52) were obtained from Whatman, Sepharose 
(6 B) from Pharmacia and Biogel (P-6) from Biorad 
Labs. Hydroxylapatite was prepared according to 
[7]. Histone (Ha) and bovine serum albumin (Cohn 
fraction V) were purchased from Sigma, pronase (CB) 
from Calbiochem and other marker proteins from 
Boehringer. Casein (Merck) was prepared according to 
[g]. Pure ox brain calcium-dependent regulator 
(CDR) preparation was a generous gift from 
Professor J. Demaille. 
2.1. Bovine adrenal cortex cytosol 
This was prepared as in [9] in TDG buffer 
(10 mM Tris-HCl (pH 7.5) containing 1 mM 
dithiothreitol and 2% glycerol). The catalytic subunit 
of the CAMP-dependent protein kinase was isolated 
from cytosol adopting the procedure in [lo]. 
2.2. Gzsein kinases of the A (PK A) and G (PK G) 
types 
These were isolated from adrenal cortex cytosol 
after adsorption onto a phosphocellulose column as 
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in [ 111. The bulk of cAMPdependent histone kinase 
was removed by washing with TDG buffer containing 
0.2 M NaCl; PK A and PK G were then eluted in a 
stepwise manner with TDG buffer containing 0.6 
and 1 M NaCl, respectively. 
2.3. Dodecyl solute ~U.~%~ slab gel electro~horesis 
This was performed in a discontinuous Tris- 
glycine buffer according to [ 121 using either a 
7.5-l 5% gradient (molecular size screening) or a 15% 
(study of small M, moieties) polyacrylamide gels. 
2.4. Protein “‘I labeling 
This was carried out using 5 Mg protein and the 
Na 12’1 (0.5 mCi)-chloramine T procedure in [ 131. 
Free iodine was removed by filtering the reaction 
mixture through a Biogel P-6 column (0.9 X 25 cm) 
in TDG buffer containing 0.1 M NaCl. 
2.5. Protein kinase assay 
This was performed under the incubation condi- 
tions in 1141 with the TCA precipitation procedure 
in [ 151. For inhibition studies, the 80 nl standard 
reaction mixture contained either 50 r_l1 enzyme 
preparation or 50 ~1 mixture of enzyme and inhibitor 
in the indicated proportion and 30 fi TDG buffer 
containing either [T-~~P]ATP or [32P]GTP (spec. act. 
1000 cpm/pmol). MgC12 and 60 pg casein were also 
present in this 30 nl aliquot unless otherwise stated. 
The final concentrations were 0.01 mM ATP (or 
GTP) and 50 mM MgC&. When the catalytic subunit 
of CAMP-dependent protein kinase was used, the 
standard reaction mixture was the same xcept hat 
it contained 1 mM MgCl, and 60 @g histone. The 
reaction was vitiated by addition of the enzyme 
preparation and incubated at 30°C under linear 
conditions with regard to time and enzyme concen- 
tration . 
2.6. Protein dete~~nations 
These were performed by the method in [16] 
using bovine serum albumin as the standard, except 
for the later purification steps where the procedure in 
[17] was adopted. 
2.7. Inhibitory activity 
This was estimated by calculation of the 50% 
inhibitory dose (1&e, mg protein) by the method in 
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[ 181. Total inhibitory activity of a given preparation 
was then expressed as the ratio of its total protein 
content o its IDSO. Thus, this ratio represents he 
volume to which the preparation must be diluted to 
yield a 50% inhibition of PK activity under standard 
assay conditions. This method of expressing the 
results was chosen since it takes into account non- 
linearity of inhibitory dose-response curves, as seen 
with most of the usual types of inhibition. 
3. Results and discussion 
3 .l . Putification of the PK G inhibitory factor 
(IX G I) from bovine adrenal cortex cytosol 
Previous experiments have shown that PK G I is 
not retained on phosphocellulose r sin at low ionic 
strength, in contrast o the A- and G-type casein 
kinases. Consequently the described preparation 
procedure was devised to yield the inhibitor as a by- 
product of the PK A and PK G isolation (using the 
same cytosol batch). 
3.1 .I. Phosphocellulose chromatography 
Crude adrenal cortex cytosol(2600 ml) was 70% 
saturated with ammonium sulfate; after centrifuga- 
tion (20 000 X g, 30 min), the precipitate was dissolved 
in TDG-O.1 M NaCl buffer (1300 ml) and dialysed 
against the same medium. The dialysate was transfered 
onto a 5 X 20 cm phospho~elluIose column pre- 
equilibrated with the same buffer and the collection 
started immediately. The bulk of inhibitory activity 
was recovered in the flow-through volume and the 
following 400 ml wash with TDG-0.2 M NaCl buffer, 
whereas the A and G casein kinases remained on the 
column and could be obtained independently Ill 1. 
3.1.2. Heat treatment, pH 4.7 precipitation and 
DEAE-cellulose chromatography 
The inhibitory fractions were heat treated for 
5 mm in a boiling water bath and the resulting 
precipitate discarded after centrifugation 
(20 000 X g, 10 min). The clear supernatant was 
brought to pH 4.7 by dropwise addition of 0.1 M 
acetic acid with constant stirring and pH control. 
The resulting precipitate was collected 
(20 000 X g, 20 min), dissolved in 12 ml distilled 
water and dialysed against 10 mM HCl-imidazole 
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buffer (pH 6.5). The preparation was then transfered 
to a 2 X 2 cm DEAE-cellulose column equilibrated 
in the same buffer. After washing with 30 ml 
HCV-imidazole buffer containing 0.2 M NaCl, a linear 
0.2-0.5 M NaCl gradient was applied and the PK G I 
activity eluted (0.28-0.45 M NaCl, 42 ml). 
3 .1.3. Hydroxylapatite chromatography and gel 
filtration 
After dialysis against 10 mM phosphate buffer 
(pH 6.8) the preparation was added to a 2 X 3.7 cm 
hydroxylapatite column prepared in the same 
medium. After a 50 ml wash with 10 mM phosphate 
buffer, a linear 1 O-200 mM phosphate gradient was 
applied. The active fractions were eluted between 
20-120 mM (56 ml) phosphate, pooled, dialysed 
against 10 mM phosphate buffer and adsorbed onto a 
0.9 X 2 cm hydroxylapatite column where they were 
concentrated. After a 5 ml washing (10 mM 
phosphate), PK G I was recovered in a small volume 
(4.3 ml) of 150 mM phosphate buffer. The preparation 
was then transfered to a 1.6 X 92 cm Sepharose (6B) 
column and eluted with 10 mM phosphate buffer 
(pH 6.8) containing 0.2 M NaCl. The pooled active 
fractions (54 ml) were dialysed against 10 mM phos- 
phate buffer (pH 6.8) and concentrated using the 
above hydroxylapatite procedure with a 0.6 X 1 .l cm 
column. The final PK G I preparation, eluted with a 
small volume of 150 mM phosphate buffer (750 d 
containing -200 pg protein), was equilibrated by 
dialysis against 10 mM phosphate buffer (pH 6.8). 
The quantitative data corresponding to the 
purification scheme are given in table 1. Since it was 
not possible to evaluate the specific inhibitory 
activity in crude cytosol, the purification factors were 
calculated on the basis of the activity found in the 
heat-treated sample. Taking into account the overall 
yield, it was calculated that the PK G I represented 
<l% of the cytosolic heat-stable proteins. The loss 
occuring at the pH 4.7 precipitation step was not due 
to partial precipitation since no PK G I activity could 
be detected in the corresponding supernatant. The 
pH 4.7 treatment had been introduced since: 
CO 
(ii) 
Separate experiments with crude PK G I prepara- 
tion had shown that 4.7 was the apparent pHi 
of PK G I activity; 
pH 4.7 treatment was very efficient in precipitating 
PK G I whereas the bulk of the HSIP in [5] 
remained in the supernatant. 
Although hydroxylapatite chromatography 
apparently did not improve the purification factor 
(table l), two protein contaminents (as judged by 
Azae) were eliminated at this stage. The final gel 
filtration through Sepharose 6B (fig.1) shows that 
this step eliminated a protein contaminent whereas 
no protein (,4Zae) could be detected in the diluted 
fraction containing the PK G I activity. The final 
inhibitor preparation appeared homogeneous upon 
Table 1 
Purification scheme of adrenal cortex PK G inhibitor 
Step 
ID,, 
(&ml) 
(A) 
Protein 
(ms) 
(B) 
Total act. Purif. 
(B/A X 1000) factor 
(ml) 
Overall 
yield 
(%I 
Heat 
treatment 
pH 4.7 
precipitate 
DEAE 
cellulose 
Hydroxyl- 
apatite 
Sepharose 
6B 
33.3 154.5 46 846 1 100 
7.29 74.50 10 205 4.6 21.8 
2.00 3.87 1935 16.7 4.1 
1.92 2.71 1412 16.7 3.0 
0.254 0.19 740 126.2 1.6 
Conditions of assays, determination of inhibitory activity (IDso) and expression of 
total inhibitory activity as in section 2 
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FRACTION NUMBER 
Fig.1. Gel filtration of PK G I through Sepharose 6B (final 
purification step). Gel filtration was performed as in 
section 3; the PK G I activity (6-o) was assayed (see 
section 2) using 30 ~1 collected fractions after a 6-fold 
dilution. A,,, was monitored (A- - -A). The column was 
calibrated using ferritin (Fer: mol. wt 460 000), Catalase 
(Cat: mol. wt 232 000) and glucose oxidase (GO: mol. wt 
140 000). 
polyacrylamide gel electrophoresis under denaturing 
conditions (see below). 
3.2. Characterization of the PK G inhibitor 
3.2.1. Molecular properties 
The isolated PK G I was obtained as a large size 
macromolecular moiety, exhibiting a polydispersity 
ranging from 2.5-4 X 10’ app. mol. wt upon gel 
filtration (fig.1). Increasing ionic strength (0.5 M 
NaCl) did not modify this characteristic. Treatment 
with pronase (5 mg/ml, 15 h at 37°C) abolished the 
inhibitory activity of the preparation. No active 
smaller size product occured during proteolysis, as 
judged by Sepharose gel filtration. DNase and RNase 
had no effect on the inhibitor; thus, a protein core 
appears to be necessary for PK G inhibitory activity. 
This was further confirmed by the ultraviolet 
absorption spectra of the PK G I, exhibiting an Azso 
max. 
Slab gel electrophoresis of the PK G I under 
denaturating conditions (0.1% SDS) was carried out 
in both 7.5 -15% gradient and 15% polyacrylamide 
FRACTK)N NUMBER 
Fig.2. SDS (O.l%)-polyacrylamide (15%) gel electrophoresis 
of PK G I. ‘*51-Labeled PK G I (200 000 cpm), PK G I 
(6 wg) and marker proteins were analysed in parallel anes 
of the gel slab. At the end of the electrophoresis run, the 
lane containing PK G I was cut into 2 mm long slices: the 
slices were extracted overnight by 50 ~1 TDG buffer 
which was then extensively dialysed against TDG buffer 
and assayed for PK G I activity (o- - -0). The remaining 
gel slab was stained by Coomassie blue (0.25%), and the lane 
containing ‘*51-labeled PK G I was sliced as before, each 
slice counted for radioactivity (e-e). Calibration was done 
using ovalbumin (OV: Mr 45 000); casein (Gas: M, 30 000); 
trypsin (Try: Mr 24 000); CDR (Mr 16 500) and lysozyme 
(Lys: Mr 14 300). 
gels. Since the inhibitor was very poorly stained by 
Coomassie brillant blue (0.25%), 12’1 labeling of the 
PK G I preparation was performed. As shown in 
fig.2, a single labeled moiety was detected under 
these conditions, co-migrating with the PK G 
inhibitory activity as detected on a parallel lane of the 
same gel. Using marker proteins, an app. mol. wt of 
Mr 16 500 was obtained for the PK G I (fig.2). In 
addition to showing homogeneity of the isolated 
PK G I, these results also suggest hat the purified 
polydisperse preparation (fig.1) may represent an 
aggregate which is dissociated in the presence of SDS. 
The lack of sensitivity to Coomassie blue may not be 
surprising since it has been reported for other 
regulatory polypeptides such as the HSIP [5,19] and 
CDR [20]. 
306 
Volume 98, number 2 FEBS LETTERS February 1979 
Fig.3. Specificity ofPK G inhibitor. Aliquots (20 ~1) of 
adrenal cortex CAMP-independent PK A (m----m) and PK G 
(o-o) and cAMPdependent ca alytic subunit (O- -0) 
preparations were assayed for protein kinase activity after 
addition of PK G I (increasing concentrations in 30 ~1). 
Each value is the mean of 3 replicates with regard to control 
values established with 8 replicates. 
3.2.2. Protein kinase inhibitory properties 
The inhibitory activity of increasing concentrations 
of PK G I was evaluated using three adrenal cortex 
protein kinase preparations, namely CAMP-indepen- 
dent A and G casein kinases and the catalytic subunit 
of the cAMPdependent histone kinase, isolated as 
above. As shown in fig.3, the i~ibito~ effect was 
specific to the casein kinase of the G-type and 
resulted in a rapid total inhibition of this activity. 
Under similar conditions, a HSIP preparation [2,.5] 
inhibited the catalytic subunit of the CAMP-depen- 
dent PK, whereas PK A and PK G were not affected. 
It was observed that the inhibitory effect was not 
dependent upon ATP (or GTP) concentrations 
(low4 -10e6 M) but could be reversed when the sub- 
strate (casein) concentration was increased. However, 
further study is needed to define the PK G inhibition 
mechanism at the molecular level and possibly 
demonstrate a substrate-i~bitor competition. It 
should be mentioned that PK G I itself was not 
phosphorylated by PK G when the reaction was 
carried out in the absence of casein. 
These data demonstrate he presence of a new 
protein kinase inhibitory factor in the bovine adrenal 
cortex cytosol; to our knowledge this is the first 
inhibitory factor specific for a particular CAMP- 
independent protein kinase activity. PK G I is 
clearly different from the known inhibitors of PK 
activities, namely the HSIP [5,19] and the non- 
specific type II inhibitor in [6] although some 
properties (e.g., heat stability, small molecular size) 
are common to these i~bitory factors. Another 
heat-stable r gulatory protein, namely the calcium- 
dependent regulator [20) appeared similar to our 
PK G I when analysed under SDS-polyacrylamide 
electrophoresis (fig.2). However, CDR (with and 
without calcium) had no effect upon our PK G 
activity. 
Although the presence of PK G and its specific 
inhibitor in the same cellular compartment and a 
possible nzyme-inhibitor complex remains to be 
demonstrated under in vivo conditions, the 
PK G-PK G I system would represent anew possible 
regulatory pathway of cellular protein klnase 
activities. Since preliminary results (unpublished) 
have shown the presence of PK G I in many bovine 
tissues in addition to the adrenal cortex, this 
regulatory system may be of general interest. 
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